利用体外方法解读PGRMC2在人类子宫内膜月经周期及体外蜕膜化中的作用
本研究前瞻性评估了PGRMC2在人子宫内膜月经周期及体外蜕膜化中的表达,使用66名卵母细胞捐赠者的77例子宫内膜活检。发现PGRMC2表达在月经周期中波动,在体外蜕膜化的hEnSCs中显著升高,敲低PGRMC2损害蜕膜化hEnSCs支持滋养层扩张的能力。
要点
- PGRMC2在晚分泌期子宫内膜表达显著低于中分泌期(P < 0.05)。
- 蜕膜化hEnSCs中PGRMC2 mRNA(P < 0.0001)和蛋白(P < 0.001)水平显著高于未蜕膜化hEnSCs。
- 敲低PGRMC2显著损害蜕膜化hEnSCs在体外模型中支持滋养层扩张的能力(P < 0.05)。
核心结论
- 子宫内膜PGRMC2在晚分泌期较中分泌期受到抑制,在蜕膜化过程中过表达,并参与胚胎植入相关通路。
研究设计与样本
- 前瞻性研究,评估人子宫内膜月经周期及体外蜕膜化中PGRMC2表达,使用66名卵母细胞捐赠者的77例子宫内膜活检。
- 采用免疫组化、RT-qPCR、蛋白质印迹、转录组和蛋白质组分析,并通过体外生长模型进行功能验证。
主要发现
- 子宫内膜PGRMC2基因表达在晚分泌期显著低于中分泌期(P < 0.05)。
- 蜕膜化hEnSCs中PGRMC2 mRNA(P < 0.0001)和蛋白(P < 0.001)水平显著高于未蜕膜化hEnSCs。
- PGRMC1和PGRMC2 mRNA在整个月经周期各阶段及蜕膜化和未蜕膜化hEnSCs中均显著高于经典PGRs(P < 0.05)。
- PGRMC2敲低后蜕膜化hEnSCs中鉴定出4687个差异表达基因和28个差异表达蛋白。
- PGRMC2敲低显著损害蜕膜化hEnSCs在体外生长模型中支持滋养层扩张的能力(P < 0.05)。
关键数值与推荐
- 2420个上调基因主要富集于内质网功能、囊泡运输、形态发生、血管生成、细胞迁移和细胞黏附。
- 2267个下调基因与有氧呼吸和蛋白质生物合成相关。
- 蛋白富集分析显示4个上调蛋白和24个下调蛋白与有氧呼吸、细胞反应、代谢、内质网蛋白定位和核糖核苷生物合成途径相关。
临床怎么用
- 作者认为PGRMC2在女性生殖中具有未知作用,并可能未来利用PGRMC2信号通路改善辅助生殖治疗。
局限性
- 功能分析受限于人子宫内膜活检的离散数量,需要更大样本量进一步研究PGRMC2在胚胎植入和妊娠维持中的潜在作用。
- 使用体外分化的纯原代子宫内膜基质细胞群不能完全代表体内子宫内膜的异质性,也不能代表不同子宫内膜细胞类型之间的旁分泌通讯。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: What is the human endometrial non-classical progesterone receptor (PGR) membrane component 2 (PGRMC2) expression pattern throughout the menstrual cycle and what role does it play during decidualization? SUMMARY ANSWER: Endometrial PGRMC2 expression fluctuates during the human menstrual cycle and is abundantly expressed in human endometrial stromal cells (hEnSCs) during in vitro decidualization, process where PGRMC2 is involved in embryo implantation-related pathways. WHAT IS KNOWN ALREADY: The endometrial response to progesterone is mediated by the classical and non-classical PGRs. We previously demonstrated that PGR membrane component 1 (PGRMC1) is critical for endometrial function, embryo implantation, and future placentation, however, the role(s) of PGRMC2, which is structurally similar to PGRMC1, have not been studied in the human endometrium. STUDY DESIGN, SIZE, DURATION: This prospective study comprehensively evaluated the endometrial expression of PGRMC2 throughout the human menstrual cycle and during in vitro decidualization of hEnSCs (isolated from 77 endometrial biopsies that were collected from 66 oocyte donors), using immunohistochemistry, RT-qPCR, western blot, transcriptomic, and proteomic analyses. In addition, functional analysis was carried out to validate the implication of PGRMC2 in hEnSCs during embryo invasion using an in vitro outgrowth model. PARTICIPANTS/MATERIALS, SETTING, METHODS: In vitro decidualization of hEnSCs was induced using co-treatment with cAMP and medroxyprogesterone 17-acetate progestin, and evaluated by measuring prolactin by ELISA and F-actin immunostaining. RT-qPCR was employed to compare expression with other PGRs. To reveal the function of PGRMC2 during the decidualization process, we specifically knocked down PGRMC2 with siRNAs and performed RNA-seq and quantitative proteomics techniques (SWATH-MS). The common differentially expressed genes (DEGs) and proteins (DEPs) were considered for downstream functional enrichment analysis. Finally, to verify its implication in the trophoblast invasion, an outgrowth model was carried out where hEnSCs with silenced PGRMC2 were co-cultured with human trophoblastic spheroids (JEG-3) following in vitro decidualization. MAIN RESULTS AND THE ROLE OF CHANCE: In contrast to PGRMC1 and classical PGRs, endometrial PGRMC2 gene expression was significantly lower during the late- versus mid-secretory phase (P < 0.05). Accordingly, the elevated PGRMC2 protein abundance observed in the endometrial epithelial glands throughout the menstrual cycle dropped in the late secretory phase, when abundance decreased in all endometrial compartments. Nevertheless, PGRMC2 protein increased during the mid-secretory phase in stromal and glandular cells, and PGRMC2 mRNA (P < 0.0001) and protein (P < 0.001) levels were significantly enhanced in the membranes/organelles of decidualized hEnSCs, compared to non-decidualized hEnSCs. Notably, PGRMC1 and PGRMC2 mRNA were significantly more abundant than classical PGRs throughout menstrual cycle phases and in decidualized and non-decidualized hEnSCs (P < 0.05). RNA-seq and proteomics data revealed 4687 DEGs and 28 DEPs, respectively, in decidualized hEnSCs after PGRMC2 silencing. While functional enrichment analysis showed that the 2420 upregulated genes were mainly associated with endoplasmic reticulum function, vesicular transport, morphogenesis, angiogenesis, cell migration, and cell adhesion, the 2267 downregulated genes were associated with aerobic respiration and protein biosynthesis. The protein enrichment analysis showed that 4 upregulated and 24 downregulated proteins were related to aerobic respiration, cellular response, metabolism, localization of endoplasmic reticulum proteins, and ribonucleoside biosynthesis routes. Finally, PGRMC2 knockdown significantly compromised the ability of the decidualized hEnSCs to support trophoblast expansion in an outgrowth model (P < 0.05). LARGE-SCALE DATA: Transcriptomic data are available via NCBI's Gene Expression Omnibus (GEO) under GEO Series accession number GSE251843 and proteomic data via ProteomeXchange with identifier PXD048494. LIMITATIONS, REASONS FOR CAUTION: The functional analyses were limited by the discrete number of human endometrial biopsies. A larger sample size is required to further investigate the potential role(s) of PGRMC2 during embryo implantation and maintenance of pregnancy. Further, the results obtained in the present work should be taken with caution, as the use of a pure primary endometrial stromal population differentiated in vitro does not fully represent the heterogeneity of the endometrium in vivo, nor the paracrine communications occurring between the distinct endometrial cell types. WIDER IMPLICATIONS OF THE FINDINGS: The repression of endometrial PGRMC2 during the late- versus mid-secretory phase, together with its overexpression during decidualization and multiple implications with embryo implantation not only highlighted the unknown roles of PGRMC2 in female reproduction but also the potential to exploit PGRMC2 signaling pathways to improve assisted reproduction treatments in the future. STUDY FUNDING/COMPETING INTEREST(S): This research was funded by Instituto de Salud Carlos III (ISCIII) granted to F.D. (PI20/00405 and PI23/00860), co-funded by the European Union. Y.M.-L. was supported by a predoctoral research grant from Generalitat Valenciana (ACIF/2019/262). R.G.-M. was supported by Generalitat Valenciana (CIAPOT/2022/15). P.d.C. was supported by a predoctoral grant for training in research into health (PFIS FI20/00086) from the Instituto de Salud Carlos III. I.D.-H. was supported by the Spanish Ministry of Science, Innovation and Universities (FPU18/01550). A.P. was supported by the Instituto de Salud Carlos III (PFIS FI18/00009). This research was also supported by IVI Foundation-RMA Global (1911-FIVI-103-FD). The authors declare no conflict of interest.
引用
- Medina-Laver Y, Gonzalez-Martin R, de Castro P, et al. Deciphering the role of PGRMC2 in the human endometrium during the menstrual cycle and in vitro decidualization using an in vitro approach. Hum Reprod. 2024. PMID: 38452349. doi:10.1093/humrep/deae044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。